Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus O Butler

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2026
CD28-driven ex vivo generation of stem-like memory CD8<sup>+</sup> T cells bypassing CD3/TCR signalingFumie Ihara, Yota Ohashi, Evey Y F Zheng, et al.
Pigment Cell & Melanoma Research|June 24, 2026
Meeting Report From the 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Amsterdam, the Netherlands, October 2025Andrew E Aplin, Katherina Alsina, Allison S Betof, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2018
A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II ConsortiumStephanie Lheureux, Anna Tinker, Blaise Clarke, et al.
Journal for Immunotherapy of Cancer|June 9, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancerMary L Disis, Sarah F Adams, Jyoti Bajpai, et al.
Science Immunology|December 15, 2019
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironmentMarie Jo Halaby, Kebria Hezaveh, Sara Lamorte, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 21, 2023
Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)Sofia Genta, Katherine Lajkosz, Noelle R Yee, et al.
Journal for Immunotherapy of Cancer|June 28, 2017
Immunotherapy biomarkers 2016: overcoming the barriersJames L Gulley, Jay A Berzofsky, Marcus O Butler, et al.
Science Translational Medicine|April 29, 2011
Establishment of antitumor memory in humans using in vitro-educated CD8+ T cellsMarcus O Butler, Philip Friedlander, Matthew I Milstein, et al.
Nature Medicine|October 13, 2022
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trialRichard D Carvajal, Marcus O Butler, Alexander N Shoushtari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2025
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 PatientsTakami Sato, Marcus O Butler, Sophie Piperno-Neumann, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2026
CD28-driven ex vivo generation of stem-like memory CD8<sup>+</sup> T cells bypassing CD3/TCR signalingFumie Ihara, Yota Ohashi, Evey Y F Zheng, et al.
Pigment Cell & Melanoma Research|June 24, 2026
Meeting Report From the 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Amsterdam, the Netherlands, October 2025Andrew E Aplin, Katherina Alsina, Allison S Betof, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2018
A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II ConsortiumStephanie Lheureux, Anna Tinker, Blaise Clarke, et al.
Journal for Immunotherapy of Cancer|June 9, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancerMary L Disis, Sarah F Adams, Jyoti Bajpai, et al.
Science Immunology|December 15, 2019
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironmentMarie Jo Halaby, Kebria Hezaveh, Sara Lamorte, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 21, 2023
Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)Sofia Genta, Katherine Lajkosz, Noelle R Yee, et al.
Journal for Immunotherapy of Cancer|June 28, 2017
Immunotherapy biomarkers 2016: overcoming the barriersJames L Gulley, Jay A Berzofsky, Marcus O Butler, et al.
Science Translational Medicine|April 29, 2011
Establishment of antitumor memory in humans using in vitro-educated CD8+ T cellsMarcus O Butler, Philip Friedlander, Matthew I Milstein, et al.
Nature Medicine|October 13, 2022
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trialRichard D Carvajal, Marcus O Butler, Alexander N Shoushtari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2025
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 PatientsTakami Sato, Marcus O Butler, Sophie Piperno-Neumann, et al.
Pageof 13